The WHO warns against counterfeit medicines used to treat diabetes and weight loss
The World Health Organization (WHO) has issued a medical product warning about counterfeit semaglutides, the type of drugs used in some countries to treat type 2 diabetes and obesity. The alert concerns three counterfeit consignments of semaglutide class medicines (of the specific brand Ozempic), which were delivered in October 2023 in Brazil, in October 2023 … Read more